Onyx Biotec Board Redesignates Naresh Kumar as MD and Sets AGM Dates
Onyx Biotec Ltd 路 Outcome 路 03 Sept 2026, 10:29 pm
Onyx Biotec Board Redesignates Naresh Kumar as MD and Sets AGM Dates Onyx Biotec Ltd. announced key board decisions on 3rd Sep'26, highlighted by the redesignation of Mr. Naresh Kumar from Whole-Time Director to Managing Director, pending shareholder approval. The board scheduled the 21st AGM for 28th Sep'26 via video conferencing. For the AGM, the e-voting cut-off date is set for 21st Sep'26, with book closure running from 22nd Sep'26 to 28th Sep'26. Additionally, M/s. K.K. Sinha & Associates was appointed as Cost Auditor, and M/s. M Shahnawaz & Associates was named scrutinizer.
Original exchange filing (PDF)
More announcements from Onyx Biotec Ltd
- Onyx Biotec Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 14 Nov 2026
- Onyx Biotec Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of corrigendum to the letter of offer for the attention to the public shareholders of the Onyx Biotec Limited. 路 12 Nov 2026
- Onyx Biotec Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- VC Corporate Advisors Private Limited has Submitted to the Exchange a copy of offer opening public announcement cum corrigendum to the detailed public statement to the public shareholders of the聽Onyx Biotec Limited (Target Company). 路 14 Oct 2026
- Onyx Biotec Limited has informed regarding Submission of the Non-Applicability of the provisions relating to Corporate Governance as specified in the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 路 14 Oct 2026
- Onyx Biotec Limited has Submitted to the Exchange a newspaper copy of the Recommendation of the Independent Director Committee ("IDC") of the company in relation to the Open Offer made by Mr. Kunal Bhardwaj ( Acquirer 1 ), Mr. Gautam Bhardwaj ( Acquirer 2 ), Mr. Kanhaiya Bhardwaj ( Acquirer 3 ) and Mr. Kapil Bhardwaj ( Acquirer 4 ) (hereinafter collectively referred to as the Acquirers ) to the public shareholders of the company under Regulation 26(7) of SEBI (SAST) Regulations, 2011 and subseq 路 08 Oct 2026
